Abstract:Protein kinase B (AKT) plays a pivotal in regulating cell migration, proliferation, apoptosis, and survival, making it a prominent target for anticancer therapy. While the kinase activity of AKT has been extensively explored, its dephosphorylation have largely remained uncharted. Herein, we aimed to unravel the molecular mechanisms governing AKT dephosphorylation, with a specific emphasis on dual-specificity phosphatases DUSP22. Our investigation sought to shed light on the potential of DUSP22 as a potential therapeutic target for non-small cell lung cancer (NSCLC). To determine the expression level of DUSP22 in NSCLC cell lines, the gene expression profiling interactive analysis (GEPIA) and Oncomine database were searched. Additionally, the effect of DUSP22 on patient survival was analyzed with Kaplan-Meier database. Antitumor effects of DUSP22 were tested in A549 and H1299 cell lines. Experiments are based on: (1) cell viability determined by the cell counting kit-8 assay and colony-formation assay; (2) cell migratory ability assessed through the scratch assay and the transwell migration assay; (3) the mechanism behind the antitumor effects of DUSP22 dissected with co-immunoprecipitation (Co-IP) and in vitro kinase assays. Our study revealed a significant downregulation of DUSP22 in both NSCLC cell lines and tissues. Meanwhile, survival rate analysis results demonstrated that reduced DUSP22 expression was correlated with poorer overall survival in lung cancer patients. Moreover, DUSP22 exhibited an inhibitory effect on the cell viability and migratory capacity of A549 and H1299 cells. This inhibition was accompanied by the decrease in the phosphorylation of AKT and p38. Mechanistically, the phosphatase domain of DUSP22 interacted with AKT, resulting in the inhibition of AKT phosphorylation. This inhibitory effect was contingent upon the phosphatase activity of DUSP22. These findings provide compelling evidence that DUSP22 directly interacted with AKT, leading to the dephosphorylation of AKT at S473 and T308 residues, ultimately curbing the proliferation and migration of lung cancer cells. Additionally, our results also highlight a preclinical rationale for utilizing DUSP22 as a prognostic marker in NSCLC.

Dual Specificity Phosphotase 18, Interacting with SAPK, Dephosphorylates SAPK and Inhibits SAPK/JNK Signal Pathway in Vivo.

Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway

Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy.

Usp49 Inhibits Ischemia-Reperfusion-Induced Cell Viability Suppression And Apoptosis In Human Ac16 Cardiomyocytes Through Dusp1-Jnk1/2 Signaling

The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1.

The MAPK dual specific phosphatase (DUSP) proteins: A versatile wrestler in T cell functionality

Molecular Cloning and Characterization of a Novel Dual-Specificity Phosphatase18 Gene from Human Fetal Brain.

Dual-specificity phosphatase 12 attenuates oxidative stress injury and apoptosis in diabetic cardiomyopathy via the ASK1-JNK/p38 signaling pathway

DUSP8 Phosphatase: Structure, Functions, Expression Regulation and the Role in Human Diseases

DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.

The Dual-Specificity Phosphatase Dusp14 Negatively Regulates Tumor Necrosis Factor- And Interleukin-1-Induced Nuclear Factor-Kappa B Activation By Dephosphorylating The Protein Kinase Tak1

Dual Specific Phosphatase 12 Ameliorates Cardiac Hypertrophy in Response to Pressure Overload

Dual-specificity Phosphatase 9 Protects Against Cardiac Hypertrophy by Targeting ASK1.

DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non-small cell lung cancer

Molecular Identification and Functional Characterization of a Drosophila Dual-Specificity Phosphatase DMKP-4 Which is Involved in PGN-induced Activation of the JNK Pathway.

Dual-Specificity Phosphatase 15 (DUSP15) Modulates Notch Signaling by Enhancing the Stability of Notch Protein

DUSP28 Contributes to Human Hepatocellular Carcinoma Via Regulation of the P38 MAPK Signaling.

DUSP16 ablation arrests the cell cycle and induces cellular senescence.

DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.

DUSP5 Suppresses Interleukin-1Β-induced Chondrocyte Inflammation and Ameliorates Osteoarthritis in Rats.

The Atypical Dual Specificity Phosphatase DUSP15 Regulates Jak1-Mediated STAT3 Activation